Both in Pharmaceuticals
Ovid Therapeutics vs Shattuck Labs
Over the past year OVID returned +106.0% and STTK returned +166.8%; their daily moves had a correlation of 0.30.
OVID +106.0% STTK +166.8%Growth of $1, one year, split-adjusted
| Metric | OVID | STTK |
|---|---|---|
| Price | $2.74 | $5.15 |
| Market cap | $535.1M | $516.9M |
| Today | +14.17% | −5.85% |
| 1 month | +15.6% | −12.1% |
| 6 months | −1.4% | −22.9% |
| Year to date | +68.1% | +41.1% |
| 1 year | +98.6% | +158.8% |
| Revenue growth (YoY) | −88.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −2047.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 338.0× | 516.9× |
| Net cash | $117.2M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | 59.6% |
| Short % of float | 10.2% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).